BACKGROUND: SHOX mutations have previously been described as causes of Léri-Weill dyschondrosteosis (LWD), Langer mesomelic dysplasia (LMD), and idiopathic short stature. The loss of X chromosome-Turner syndrome or mosaic 45,X/46,XX or 46,XY-also leads to the heterozygous loss of SHOX in patients with short stature only or with features similar to LWD. The aim of this study was to assess the efficacy of the targeted screening for SHOX variants, which involved different methods in the laboratory analysis of short stature. We determined the significance and positive predictive value of short stature for the detection of SHOX variants. METHODS: Targeted screening for variants in SHOX involving MLPA, sequencing, karyotyping and FISH was performed in the short stature cohort (N = 174) and control cohort (N = 91). The significance of short stature and particular characteristics for the detection of SHOX variants was determined by Fisher's exact test, and the probability of SHOX mutation occurrence was calculated using a forward/stepwise logistic regression model. RESULTS: In total, 27 and 15 variants influencing SHOX were detected in the short stature and control cohorts, respectively (p > 0.01). Sex chromosome aberrations and pathogenic CNV resulting in diagnosis were detected in eight (4.6%) and five (2.9%) patients of the short stature group and three (3.3%) and one (1.1%) individuals of the control group. VUS variants were discovered in 14 (8.0%) and 11 (12.1%) individuals of the short stature and control groups, respectively. MLPA demonstrated the detection rate of 13.22%, and it can be used as a frontline method for detection of aberrations involving SHOX. However, only mosaicism of monosomy X with a higher frequency of monosomic cells could be reliably discovered by this method. Karyotyping and FISH can compensate for this limitation; their detection rates in short stature group were 3.55% and 13.46% (N = 52), respectively. FISH proved to be more effective than karyotyping in the study as it could reveal cryptic mosaics in some cases where karyotyping initially failed to detect such a clone. We suggest adding FISH on different tissue than peripheral blood to verify sex-chromosome constitution, especially in cases with karyotypes: 45,X; mosaic 45,X/46,XX or 46,XY; 46,Xidic(Y) detected from blood; in children, where mosaic 45,X was detected prenatally but was not confirmed from peripheral blood. The correlation of short stature with the occurrence of SHOX mutations was insignificant and short stature demonstrates a low positive predictive value-15.5% as unique indicator for SHOX mutations. The typical skeletal signs of LWD, including Madelung deformity and disproportionate growth, positively correlate with the findings of pathogenic SHOX variants (p < 0.01) by Fisher's exact test but not with the findings of VUS variants in SHOX which are more prevalent in the individuals with idiopathic short stature or in the individuals with normal height.

Department of Medical Genetics Faculty of Medicine and Dentistry Palacky University Olomouc Olomouc Czech Republic

Department of Medical Genetics University Hospital Olomouc Olomouc Czech Republic

Department of Pediatrics Faculty of Medicine and Dentistry Palacky University Olomouc Olomouc Czech Republic

See more in PubMed

Alharthi AA, El-Hallous EI, Talaat IM, Alghamdi HA, Almalki MI, Gaber A. Screening of SHOX gene sequence variants in Saudi Arabian children with idiopathic short stature. Korean Journal of Pediatrics. 2017;60(10):327–332. doi: 10.3345/kjp.2017.60.10.327. PubMed DOI PMC

Amin N, Mushtaq T, Alvi S. Fifteen-minute consultation: the child with short stature. Archives of Disease in Childhood—Education and Practice. 2015;100:180–184. PubMed

Belin V, Cusin V, Viot G, Girlich D, Toutain A, Moncla A, Vekemans M, Le Merrer M, Munnich A, Cormier-Daire V. SHOX mutations in dyschondrosteosis (Leri-Weill syndrome) Nature Genetics. 1998;19:67–69. doi: 10.1038/ng0198-67. PubMed DOI

Benito-Sanz S, Aza-Carmona M, Magano LF, Lapunzina P, Argente J, Campos-Barros A, Heath KE. PAR1 deletions downstream of SHOX are the most frequent defect in a Spanish cohort of Léri-Weill dyschondrosteosis (LWD) probands. Human Mutation. 2006;27(10):1062–1068. doi: 10.1002/humu.9456. PubMed DOI

Benito-Sanz S, Barroso E, Heine-Suñer D, Hisado-Oliva A, Romanelli V, Rosell J, Aragones A, Caimari M, Argente J, Ross JL, Zinn AR, Gracia R, Lapunzina P, Campos-Barros A, Heath KE. Clinical and molecular evaluation of SHOX/PAR1 duplications in Leri-Weill dyschondrosteosis (LWD) and idiopathic short stature (ISS) The Journal of Clinical Endocrinology and Metabolism. 2011;96(2):E404-12. doi: 10.1210/jc.2010-1689. PubMed DOI

Benito-Sanz S, Royo JL, Barroso E, Paumard-Hernández B, Barreda-Bonis AC, Liu P, Gracia R, Lupski JR, Campos-Barros A, Gómez-Skarmeta JL, Heath KE. Identification of the first recurrent PAR1 deletion in Léri-Weill dyschondrosteosis and idiopathic short stature reveals the presence of a novel SHOX enhancer. Journal of Medical Genetics. 2012;49(7):442–450. doi: 10.1136/jmedgenet-2011-100678. PubMed DOI

Benito-Sanz S, Thomas NS, Huber C, Gorbenko del Blanco D, Aza-Carmona M, Crolla JA, Maloney V, Rappold G, Argente J, Campos-Barros A, Cormier-Daire V, Heath KE. A novel class of Pseudoautosomal region 1 deletions downstream of SHOX is associated with Leri-Weill dyschondrosteosis. American Journal of Medical Genetics. 2005;77(4):533–544. doi: 10.1086/449313. PubMed DOI PMC

Binder G. Short stature due to SHOX deficiency: genotype, phenotype, and therapy. Hormone Research in Paediatrics. 2011;75(2):81–89. doi: 10.1159/000324105. PubMed DOI

Blum WF, Ross JL, Zimmermann AG, Quigley CA, Child CJ, Kalifa G, Deal C, Drop SL, Rappold G, Cutler Jr GB. GH treatment to final height produces similar height gains in patients with SHOX deficiency and turner syndrome: results of a multicenter trial. The Journal of Clinical Endocrinology & Metabolism. 2013;98(8):E1383–E1392. doi: 10.1210/jc.2013-1222. PubMed DOI

Caliebe J, Broekman S, Boogaard M, Bosch CA, Ruivenkamp CA, Oostdijk W, Kant SG, Binder G, Ranke MG, Wit JM, Losekoot M. IGF1, IGF1R and SHOX mutation analysis in short children born small for gestational age and short children with normal birth size (idiopathic short stature) Hormone Research in Paediatrics. 2012;77(4):250–260. doi: 10.1159/000338341. PubMed DOI

Campos-Barros A, Benito-Sanz S, Ross JL, Zinn AR, Heath KE. Compound heterozygosity of SHOX-encompassing and downstream PAR1 deletions results in Langer mesomelic dysplasia (LMD) American Journal of Medical Genetics, part A. 2007;143A(9):933–938. doi: 10.1002/ajmg.a.31676. PubMed DOI

Chen J, Wildhardt G, Zhong Z, Röth R, Weiss B, Steinberger D, Decker J, Blum WF, Rappold G. Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250 kb downstream regulatory domain. Journal of Medical Genetics. 2009;46(12):834–839. doi: 10.1136/jmg.2009.067785. PubMed DOI PMC

Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, Chernausek SD, Savage MO, Wit JM. ISS Consensus Workshop participants. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. Journal of Clinical Endocrinology and Metabolism. 2008;93(11):4210–4217. doi: 10.1210/jc.2008-0509. PubMed DOI

Collett-Solberg PF, Ambler G, Backeljauw PF, Bidlingmaier M, Biller BMK, Boguszewski MCS, Cheung PT, Choong CSY, Cohen LE, Cohen P, Dauber A, Deal CL, Gong C, Hasegawa Y, Hoffman AR, Hofman PL, Horikawa R, Jorge AAL, Juul A, Kamenický P, Khadilkar V, Kopchick JJ, Kriström B, Lopes MDLA, Luo X, Miller BS, Misra M, Netchine I, Radovick S, Ranke MB, Rogol AD, Rosenfeld RG, Saenger P, Wit JM, Woelfle J. Diagnosis, genetics, and therapy of short stature in children: a growth hormone research society international perspective. Hormone Research in Paediatrics. 2019;92:1–14. doi: 10.1159/000502231. PubMed DOI PMC

D’angelo CS, Varela MC, Otto PA, Perez A, Lourenço CM, Kim CA, Bertola DR, Kok F, Garcia-Alonso L, Priszkulnik C. Chromosomal microarray analysis in the genetic evaluation of 279 patients with syndromic obesity. Molecular Cytogenetics. 2018;11(11):14–32. doi: 10.1186/s13039-018-0363-7. PubMed DOI PMC

Dauber A, Rosenfeld RG, Hirschhorn JN. Genetic evaluation of short stature. Journal of Clinical Endocrinology. 2014;99(9):3080–3092. doi: 10.1210/jc.2014-1506. PubMed DOI PMC

Dávid A, Butz H, Halász Z, Török D, Nyirő G, Muzsnai Á, Csákváry V, Luczay A, Sallai Á andHosszú, É, Felszeghy E, Tar A, Szántó Z, Fekete GL, Kun I, Patócs A, Bertalan R. The prevalence of SHOX gene deletion in children with idiopathic short stature. A multicentric study. Orvosi Hetilap. 2017;158(34):1351–1356. doi: 10.1556/650.2017.30829. PubMed DOI

Denes AM, Landin-Wilhelmsen K, Wettergren Y, Bryman I, Hanson C. The proportion of diploid 46, XX cells increases with time in women with Turner syndrome—a 10-year follow-up study. Genetic Testing and Molecular Biomarkers. 2015;19(2):82–87. doi: 10.1089/gtmb.2014.0240. PubMed DOI PMC

Durand C, Roeth R, Dweep H, Vlatkovic I, Decker E, Schneider KU, Rappold G. Alternative splicing and nonsense-mediated RNA decay contribute to the regulation of SHOX expression. PLOS ONE. 2011;6(3):e18115. doi: 10.1371/journal.pone.0018115. PubMed DOI PMC

Fukami M, Nishi Y, Hasegawa Y, Miyoshi Y, Okabe T, Haga N, Nagai T, Tanaka T, Ogata P. Statural growth in 31 Japanese patients with SHOX haploinsufficiency: support for a disadvantageous effect of gonadal estrogens. Endocrine Journal. 2004;51(2):197–200. doi: 10.1507/endocrj.51.197. PubMed DOI

Hes FJ, Madan K, Rombout-Liem IS, Szuhai K, Sørensen H, Bakker E, Visser TJ, Smit JW, Hansson K. Multiple genomic aberrations in a patient with mental retardation and hypogonadism: 45, X/46, X, psu dic(Y) karyotype, thyroid hormone receptor beta (THRB) mutation and heterozygosity for Wilson disease. American Journal of Medical Genetics. 2009;149A(10):2231–2235. doi: 10.1002/ajmg.a.33004. PubMed DOI

Hirschfeldova K, Solc R. Comparison of SHOX and associated elements duplications distribution between patients (Lėri-Weill dyschondrosteosis/idiopathic short stature) and population sample. Gene. 2017;627:164–168. doi: 10.1016/j.gene.2017.06.034. PubMed DOI

Hirschfeldova K, Solc R, Baxova A, Zapletalova J, Kebrdlova V, Gaillyova R, Prasilova S, Soukalova J, Mihalova R, Lnenicka P, Florianova M, Stekrova J. SHOX gene defects and selected dysmorphic signs in patients of idiopathic short stature and Léri-Weill dyschondrosteosis. Gene. 2012;491(2):123–127. doi: 10.1016/j.gene.2011.10.011. PubMed DOI

Hook EB, Warburton D. Turner syndrome revisited: review of new data supports the hypothesis that all viable 45, X cases are cryptic mosaics with a rescue cell line, implying an origin by mitotic loss. Human Genetics. 2014;133:417–424. doi: 10.1007/s00439-014-1420-x. PubMed DOI

Huber C, Rosilio M, Munnich A, Cormier-Daire V. High incidence of SHOX anomalies in individuals with short stature. Journal of Medical Genetics. 2006;43(9):735–739. doi: 10.1136/jmg.2006.040998. PubMed DOI PMC

Kant SG, Broekman SJ, De Wit CC, Bos M, Scheltinga SA, Bakker E, Oostdijk W, Van der Kamp HJ, Van Zwet EW, Van der Hout AH, Wit JM, Losekoot M. Phenotypic characterization of patients with deletions in the 3′-flanking SHOX region. PeerJ. 2013;1(1):e35. doi: 10.7717/peerj.35. PubMed DOI PMC

Kaprova-Pleskacova J, Snajderova M, Stoop J, Koudova M, Kocarek E, Novotna D, Drop SLS, Obermannova B, Lebl J, Oosterhuis JW, Looijenga LH. 45, X/46, X, psu dic(Y) gonadal dysgenesis: influence of the two cell lines on the clinical phenotype, including gonadal histology. Sexual Development: Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, And Pathology Of Sex Determination And Differentiation. 2013;7(6):282–288. doi: 10.1159/000356173. PubMed DOI

Lebl J, Zapletalova J. Léčba růstovým hormonem v pediatrii. Historie a současnost. Klinická Farmakologie a Farmacie. 2011;25(1):18–23.

Nomura R, Miyai K, Okada M, Kajiwara M, Ono M, Ogata T, Onishi I, Sato M, Sekine M, Akashi T, Mizutani S, Kashimada K. A 45, X/46, XY DSD (Disorder of Sexual Development) case with an extremely uneven distribution of 46, XY cells between lymphocytes and gonads. Clinical Pediatric Endocrinology. 2015;24(1):11–14. doi: 10.1297/cpe.24.11. PubMed DOI PMC

Ogata T, Kosho T, Wakui K, Fukushima Y, Yoshimoto M, Miharu N. Short stature homeobox-containing gene duplication on the der(X) chromosome in a female with 45, X/46, X, der(X), gonadal dysgenesis, and tall stature. The Journal of Clinical Endocrinology & Metabolism. 2000;85(8):2927–2930. doi: 10.1210/jc.85.8.2927. PubMed DOI

Oliveira CS, Alves C. The role of the SHOX gene in the pathophysiology of Turner syndrome. Endocrinologia Y Nutricion: Organo De La Sociedad Espanola De Endocrinologia Y Nutricion. 2011;58(8):433–442. doi: 10.1016/j.endonu.2011.06.005. PubMed DOI

Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A, Muroya K, Binder G, Kirsch S, Winkelmann M, Nordsiek G, Heinrich U, Beuning MH, Ranke MB, Rosenthal A, Ogata T, Rappold G. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure idiopathic short stature and Turner syndrome. Nature Genetics. 1997;16:54–63. doi: 10.1038/ng0597-54. PubMed DOI

Rappold G, Blum WF, Shavrikova EP, Crowe BJ, Roeth R, Quigley CA, Ross JL, Niesler B. Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency. Journal Of Medical Genetics. 2007;44(5):306–313. doi: 10.1136/jmg.2006.046581. PubMed DOI PMC

Rappold GA, Fukami M, Niesler B, Schiller S, Zumkeller W, Bettendorf M, Vlachopapadoupoulou E, Reinehr T, Onigata K, Ogata T. Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature. Journal of Clinical Endocrinology and Metabolism. 2002;87(3):1402–1406. doi: 10.1210/jcem.87.3.8328. PubMed DOI

Richter-Unruh A, Knauer-Fischer S, Kaspers S, Albrecht B, Gillessen-Kaeasbach G, Hauffa BP. Short stature in children with an apparently normal male phenotype can be caused by 45, X/46, XY mosaicism and is susceptible to growth hormone treatment. European Journal of Pediatrics. 2004;163:251–256. doi: 10.1007/s00431-004-1406-0. PubMed DOI

Roos L, Nielsen KB, Tümer Z. A duplication encompassing the SHOX gene and the downstream evolutionarily conserved sequences. American Journal of Medical Genetics, part (A) 2009;149A:2900–2901. doi: 10.1002/ajmg.a.33118. PubMed DOI

Sandoval GT, Jaimes GC, Barrios MC, Cespedes C, Velasco HM. SHOX gene and conserved noncoding element deletions/duplications in Colombian patients with idiopathic short stature. Molecular Genetics. 2014;2(2):95–102. doi: 10.1002/mgg3.39. PubMed DOI PMC

Seaver LH, Irons M, American College of Medical Genetics (ACMG) Professional Practice and Guidelines Committee ACMG practice guideline: genetic evaluation of short stature. Genetics in Medicine. 2009;11(6):465–470. doi: 10.1097/GIM.0b013e3181a7e8f8. PubMed DOI PMC

Shankar RK, Backeljauw PF. Current best practice in the management of Turner syndrome. Therapeutic Advances in Endocrinology and Metabolism. 2018;9(1):33–40. doi: 10.1177/2042018817746291. PubMed DOI PMC

Sisley S, Trujillo MV, Khoury J, Backeljauw P. Low incidence of pathology detection and high cost of screening in the evaluation of asymptomatic short children. The Journal of Pediatrics. 2013;163(4):1045–1051. doi: 10.1016/j.jpeds.2013.04.002. PubMed DOI PMC

Soucek O, Zapletalova J, Zemkova D, Snajderova M, Novotna D, Hirschfeldova K, Plasilova I, Kolouskova S, Rocek M, Hlavka Z, Lebl J, Sumník Z. Prepubertal girls with Turner syndrome and children with isolated SHOX deficiency have similar bone geometry at the radius. The Journal of Clinical Endocrinology & Metabolism. 2013;98(7):E1241–E1247. doi: 10.1210/jc.2013-1113. PubMed DOI

Thomas NS, Harvey JF, Bunyan DJ, Rankin J, Grigelioniene G, Bruno DI, Tan TY, Tomkins S, Hastings R. Clinical and molecular characterization of duplications encompassing the human SHOX gene reveal a variable effect on stature. American Journal of Medical Genetics. 2009;149A(7):1407–1414. doi: 10.1002/ajmg.a.32914. PubMed DOI

Upners EN, Jensen RB, Rajpert-De Meyts E, Dunø M, Aksglaede L, Juul A. Short stature homeobox-containing gene duplications in 3.7% of girls with tall stature and normal karyotypes. Acta Paediatrica, International Journal of Paediatrics. 2017;106(10):1651–1657. doi: 10.1111/apa.13969. PubMed DOI

Valetto A, Bertini V, Michelucci A, Toschi B, Dati E, Baroncelli GI, Bertelloni S. Short Stature in Isodicentric Y Chromosome and Three Copies of the SHOX Gene: clinical Report and Review of Literature. Molecular Syndromology. 2016;7(1):19–25. doi: 10.1159/000444430. PubMed DOI PMC

Wit JM, Clayton PE, Rogol AD, Savage MO, Saenger PH, Cohen P. Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Hormone. 2008;18(2):89–110. doi: 10.1016/j.ghir.2007.11.004. PubMed DOI

Wolters B, Lass N, Wunsch R, Böckmann B, Austrup F, Reinehr T. Short stature before puberty: which children should be screened for SHOX deficiency? Hormone Research in Paediatrics. 2013;80:273–280. doi: 10.1159/000354989. PubMed DOI

Zapletalova J, Lebl J, Baxova A, Hirschfeldova K. Defekt v SHOX genu—příčina familiárního malého vzrůstu. Remedia. 2010;20(5):313–318.

Zinn AR, Wei F, Zhang L, Elder FF, Marttila P, Ross JL. Complete SHOX deficiency causes Langer mesomelic dysplasia. American Journal of Medical Genetics. 2002;110(2):158–163. doi: 10.1002/ajmg.10422. PubMed DOI